0001127602-17-001022.txt : 20170105
0001127602-17-001022.hdr.sgml : 20170105
20170105153934
ACCESSION NUMBER: 0001127602-17-001022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTIN JOHN C
CENTRAL INDEX KEY: 0001190578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 17510421
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-01-03
0000882095
GILEAD SCIENCES INC
GILD
0001190578
MARTIN JOHN C
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Executive Chairman
Common Stock
2017-01-03
4
M
0
73337
21.575
A
3204433
D
Common Stock
2017-01-03
4
S
0
22577
73.0369
D
3181856
D
Common Stock
2017-01-03
4
S
0
50760
73.838
D
3131096
D
Non-qualified Stock Option (Right to Buy)
21.575
2017-01-03
4
M
0
73337
0
D
2018-01-30
Common Stock
73337
806663
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The options have a five year vesting schedule. 20% of the options will vest on January 30, 2009, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on January 30, 2013.
Sale prices reported for the transactions reported here range from $72.33 to $73.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $73.34 to $74.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ Marissa Song by Power of Attorney for John C. Martin
2017-01-05